Tauopathies therapy(MeiraGTX)

N/A

Report date: 2022/12/13 13:22:44
NME

Base Information

Drug NameTauopathies therapy(MeiraGTX)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated protein tau inhibitors
TargetsMicrotubule-associated protein tau
Therapy Area/IndicationsTauopathiesDyskinesiasDementia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesMeiragtx Ltd
China Registration ClassN/A

Develop Information

Active CompaniesMeiragtx Ltd
Inactive CompaniesN/A
Active IndicationsTauopathiesDyskinesiasDementia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A